Navigation Links
SRI announces selection by the National Cancer Institute as a Chemical Biology Consortium center
Date:7/22/2009

Menlo Park, Calif.July 22 , 2009SRI International, an independent nonprofit research and development organization, announced today that SRI's Center for Cancer Research was selected by the National Cancer Institute (NCI) for a leading role in the newly-formed "Chemical Biology Consortium" (CBC), a collaborative drug discovery partnership focused on advancing new cancer therapeutics active against novel molecular and genetic cancer targets. Based on its track record of cancer drug discovery and development, SRI was chosen to lead three of the CBC's research and development centers: Comprehensive Chemical Biology Screening, Chemical Diversity, and Specialized Applications.

SRI has decades of experience in successfully identifying, developing and advancing novel compounds into clinical evaluation. SRI's Center for Cancer Research, comprised of biologists and medicinal chemists with expertise in fundamental and applied cancer research, focuses on the study of tumor microenvironment, tumor metabolism, and aberrant signaling pathways that cause cancer. Through collaborative partnerships, SRI's Center for Cancer Research has been successful in generating an extensive drug pipeline translating discoveries into beneficial treatments. SRI's drug discovery process, guided by a combination of biological screens and computational methods, will be a key component of the NCI Chemical Biology Consortium program.

"SRI is proud to be selected to join this innovative NCI program and to continue our long-standing support of NCI's mission to discover, develop, and bring new drugs to cancer patients," said Lidia Sambucetti, Ph.D., senior director of SRI's Center for Cancer Research. "Our multidisciplinary research team will bring proven expertise in fundamental and applied cancer research, backed by SRI's fully-integrated preclinical capabilities."

The goal of the Chemical Biology Consortium is to discover and develop new cancer therapeutics, particularl
'/>"/>

Contact: Dina Basin
dina.basin@sri.com
650-859-3845
SRI International
Source:Eurekalert

Page: 1 2

Related biology news :

1. IOS Press announces launch of Journal of Berry Research
2. Aware, Inc. Announces Q209 Earnings Conference Call
3. Supply-Chain Council Announces New Board of Directors and Officers
4. Ecological Society of America announces 2009 award recipients
5. Elsevier announces 2008 journal impact factor highlights
6. delSECUR CORPORATION Announces Appointment of the Companys President & CEO
7. Government of Canada announces funding for research on the H1N1 flu virus
8. SRI International announces findings from new upper atmospheric radar system for scientific research
9. International Serious Adverse Events Consortium announces initial study results in its global research collaboration to identify genetic markers related to drug induced liver injury
10. NSF announces funding for Alaska Region Research Vessel
11. NIH announces new program to develop therapeutics for rare and neglected diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... that the effects of a commonly used anesthetic drug ... The study, published in this week,s issue of the ... at the University of California, San Diego and Weill ... concerns, arising from multiple studies on humans over the ... increase their susceptibility to long-term cognitive and behavioral deficits, ...
(Date:7/28/2014)... Ore. The findings of a new study suggest two ... may not work as well in obese women, compared to ... pills are a one-size-fits-all method, researchers say, but as the ... well the pill works for obese women. Studies have consistently ... in the body, which may in turn affect how well ...
(Date:7/28/2014)... 28, 2014) Rice University researchers are using magnetic ... flexibility that can be used as microscale models for ... "bead-spring" polymers, introduced as theory in the 1950s, can ... and should be of interest to materials scientists who ... led by Rice chemical and biomolecular engineer Sibani Lisa ...
Breaking Biology News(10 mins):Study suggests disruptive effects of anesthesia on brain cell connections are temporary 2Study suggests disruptive effects of anesthesia on brain cell connections are temporary 3Strategies identified to improve oral contraceptive success with obese women 2Seeing is bead-lieving 2
... 2013  The following is being released by Wake Forest ... What:  A briefing for ... developments at Wake Forest Baptist Medical Center. Speakers are ... John D. McConnell , ...
... newly described species Alburnoides manyasensis , belongs the large ... as he carps, the minnows, and their relatives. This is ... of vertebrate animals, with the remarkable numbers of over 2,400 ... the largest part of biomass in most water types except ...
... to Research Careers) Program has announced the travel award ... 2013 meeting in Woods Hole, MA from March 9-14, ... of underrepresented minority students, postdoctorates and scientists into the ... the participation of young scientists at The Histochemical Society ...
Cached Biology News:Wake Forest Innovations Announces New Commercialization Developments 2
(Date:7/28/2014)...  David Hardison, Ph.D., vice president of health ... been elected chairman of the board for the ... to establish common protocols around the use of ... electronic health records. Hardison will ... organizations across the research and health care arena ...
(Date:7/28/2014)... 2014 The global market for biotechnology ... according to a new study by Grand View Research, ... for effective vaccines and drugs in an attempt to ... is expected to drive market demand over the next ... productivity via the use of genetically engineered seeds is ...
(Date:7/26/2014)... 2014 Canada Endoscopy Visualization Systems ... on the Canada Endoscopy Visualization Systems market. The ... volume (in units) and average prices (in US ... Systems, Mid-Range Endoscopy Visualization Systems and Low-End Endoscopy ... http://www.marketresearchreports.biz/analysis/213254 . , The report also provides company ...
(Date:7/25/2014)... , July 25, 2014 ... the "Global Metabolomics Market 2014-2018" report ... http://photos.prnewswire.com/prnh/20130307/600769 Metabolomics or Metabonomics is ... Metabolomics has become a new experimental technique that ... the environmental sciences. Metabolites are small molecules that ...
Breaking Biology Technology:ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 2ConvergeHEALTH by Deloitte's David Hardison Named Chairman of the Clinical Data Interchange Standards Consortium 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 2Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 3Global Biotechnology Market Worth $604.40 Billion by 2020: Grand View Research, Inc 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 2Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 3Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 4Canada Endoscopy Visualization Systems Market Outlook to 2020: MarketResearchReports.Biz 5Global Metabolomics Market 2014-2018: Key Vendors are Agilent, Bio-Rad, Bruker, Human Metabolome and Metabolon 2
... DxTech Enters Into Long-Term Strategic Alliance With Nicholas Piramal ... Point-of-Care Diagnostic ... DxTech LLC,("DxTech"), an innovation company focused on putting high-quality,diagnostic ... has entered,into a long-term strategic alliance with Nicholas Piramal ...
... of Sepracor Inc. (Nasdaq: SEPR ), ... Limited (ASX: HTW) today announced that,veteran healthcare executive ... as a non- executive director, effective immediately., ... chief executive,officer and chairman of Marlborough, MA-based Sepracor ...
... PARIS, April 30 ExonHit Therapeutics S.A.,(Alternext: ALEHT), ... its Supervisory Board., Following the annual shareholders, ... 25th, 2008, Mr. Edmund Olivier de Vezin,s appointment ... of the Board, expired,as he has reached the ...
Cached Biology Technology:DxTech and Nicholas Piramal in POC Diagnostics Alliance 2DxTech and Nicholas Piramal in POC Diagnostics Alliance 3DxTech and Nicholas Piramal in POC Diagnostics Alliance 4DxTech and Nicholas Piramal in POC Diagnostics Alliance 5HeartWare Appoints Timothy J. Barberich to Board of Directors 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 2Frederic Desdouits Appointed Member of the Supervisory Board of ExonHit Therapeutics 3